 <table>
    <tr>List of all ADCs that were explored for this study</tr>
    <tr>
      <th>ADC</th>
      <th>Payload</th>
      <th>DLT</th>
      <th>Comments</th>
    </tr>
    <tr>
      <td>T-DM1</td>
      <td>DM1</td>
      <td>thrombocytopenia</td>
      <td></td>
    </tr>
    <tr>
      <td>T-Dxd</td>
      <td>Dxd</td>
      <td></td>
      <td></td>
    </tr>
    <tr>
      <td>Cantuzumab mertansine</td>
      <td>DM1</td>
      <td>liver tox</td>
      <td>used in tde DM1 section</td>
    </tr>
    <tr>
      <td>Cantuzumab Ravtansine</td>
      <td>DM4</td>
      <td>ocular tox</td>
      <td>DAR cannot be found</td>
    </tr>
    <tr>
      <td>PCA062</td>
      <td>DM1</td>
      <td>thrombocytopenia</td>
      <td>not added to tde DM1 section bc I cannot tell a story</td>
    </tr>
    <tr>
      <td>IMGN853</td>
      <td>DM4</td>
      <td></td>
      <td>used in tde DM4 section</td>
    </tr>
    <tr>
      <td>SAR408701</td>
      <td>DM4</td>
      <td></td>
      <td>used in tde DM4 section</td>
    </tr>
    <tr>
      <td>Loncastuximab Tesirine (ADCT-402)</td>
      <td>PBD</td>
      <td></td>
      <td>cannot tell a story</td>
    </tr>
    <tr>
      <td>Mipasetamab Uzoptirine (ADCT-601)</td>
      <td>PBD</td>
      <td></td>
      <td>cannot tell a story</td>
    </tr>
    <tr>
      <td>MEDI2228</td>
      <td>PBD</td>
      <td></td>
      <td>cannot tell a story</td>
    </tr>
    <tr>
      <td>DHES0815</td>
      <td>PBD</td>
      <td></td>
      <td>tox likely to be on-target</td>
    </tr>
</table>